Item 7.01 Regulation FD Disclosure.

On September 13, 2021, Galectin Therapeutics Inc. (the "Company) posted to its website a presentation which is attached hereto as Exhibit 99.1.

The information in this report is being furnished pursuant to this Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act of 1933 or under the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to this report.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit Number        Description

99.1                    Corporate Overview Presentation, September 2021

104                   Cover Page Interactive Data File (embedded within the Inline
                      XBRL document).




                                     - 2 -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses